Supplementary Table 1 from DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody–Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma

Authors:
  • DLDongwei Li
    Dongwei Li
  • KPKirsten Achilles Poon
    Kirsten Achilles Poon
  • SYShang-Fan Yu
    Shang-Fan Yu
  • RDRandall Dere
    Randall Dere
  • MGMaryAnn Go
    MaryAnn Go
  • JLJeffrey Lau
    Jeffrey Lau
  • BZBing Zheng
    Bing Zheng
  • KEKristi Elkins
    Kristi Elkins
  • DDDimitry Danilenko
    Dimitry Danilenko
  • KKKatherine R. Kozak
    Katherine R. Kozak
  • PCPamela Chan
    Pamela Chan
  • JCJosefa Chuh
    Josefa Chuh

Abstract
XLSX file - 30K, IC50 concentrations and CD22 expression levels for cell lines.